Showing results (1-10 of 28,378) with videos related to

Sort By:
Pageof 2,838
Immunotherapy|July 20, 2010
Immunotherapy for prion diseases: opportunities and obstaclesLi Li, Scott Napper, Neil R Cashman
Vaccine|July 21, 2019
Therapeutic vaccines for amyotrophic lateral sclerosis directed against disease specific epitopes of superoxide dismutase 1Beibei Zhao, Kristen Marciniuk, Ebrima Gibbs, et al.
Vaccine|November 21, 2009
Design and delivery of a cryptic PrP(C) epitope for induction of PrP(Sc)-specific antibody responsesPeter D Hedlin, Neil R Cashman, Li Li, et al.
Prion|October 10, 2013
PrP(Sc)-specific antibodies do not induce prion disease or misfolding of PrP(C) in highly susceptible Tga20 micePekka Määttänen, Ryan Taschuk, Li Ross, et al.
Prion|January 10, 2014
Nanopore analysis reveals differences in structural stability of ovine PrP(C) proteins corresponding to scrapie susceptible (VRQ) and resistance (ARR) genotypesClaudia Avis Madampage, Kristen Marciniuk, Pekka Määttänen, et al.
Vaccine|February 4, 2014
Development of a multivalent, PrP(Sc)-specific prion vaccine through rational optimization of three disease-specific epitopesKristen Marciniuk, Pekka Määttänen, Ryan Taschuk, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentNeil R Cashman, Steven S Plotkin, Scott Napper, et al.
Prion|June 22, 2013
Binding of bovine T194A PrP(C) by PrP(Sc)-specific antibodies: potential implications for immunotherapy of familial prion diseasesClaudia A Madampage, Pekka Määttänen, Kristen Marciniuk, et al.
Prion|February 11, 2014
Safety, specificity and immunogenicity of a PrP(Sc)-specific prion vaccine based on the YYR disease specific epitopeRyan Taschuk, Kristen Marciniuk, Pekka Määttänen, et al.
Biochemical and Biophysical Research Communications|October 30, 2007
Species barriers for chronic wasting disease by in vitro conversion of prion proteinLi Li, Michael B Coulthart, Aru Balachandran, et al.
Pageof 2,838